A retrospective data analysis of vulvar dysplasia (2021–2025) at UKB: natural history and recurrence rates across different treatment modalities, considering relevant risk factors.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039809

Enrollment

131

Registered

2026-04-15

Start date

2026-04-14

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N90.3

Interventions

Group 1: Retrospective, non-interventional observational study based on routinely collected clinical data from patients with vulvar dysplasia treated at the University Hospital Bonn between 2021 and 2

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients treated for vulvar dysplasia at the University Hospital Bonn between 2021 and 2025.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Recurrence-free survival, defined as the time from initial treatment to first documented recurrence, assessed over the follow-up period up to 2025.	—

Secondary

Measure	Time frame
Overall remission rate Progression rate Impact of co-factors (smoking status, presence of Lichen sclerosus, high-risk HPV status, parity)	—

Countries

Germany

Contacts

Public ContactLucia Otten

Uniklinikum Bonn

Lucia.Otten@ukbonn.de+4915158233445

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026